is liraglutide a glp 1 Structure of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists GLP-1 Drug Comparison in Diabetes

Peri-lesional injection requires precise anatomical knowledge and a higher technical skill level, and the marginal benefit over subcutaneous delivery is not clearly established

About 5 to 7 percent of people who are on treatment stop because of side effects in their stomachs

It is the most bioavailable form of B12, and also the most active, working mostly in our brains, nervous system, and liver (Lindstrand, 1964)

Dosage, sourcing, and monitoring are crucial to ensure safety and effectiveness

It is dosed between 300 mcg and 1,000 mcg (1 mg) daily, either subcutaneously or via an intranasal applicator

small bottles with nasal spray caps)